Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Mytesi
Mytesi Image

Mytesi

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Mytesi?

Mytesi is the brand name for a prescription medication called crofelemer. It is specifically indicated for the treatment of non-infectious diarrhea in adults who are taking antiretroviral therapy (ART) for HIV infection. Diarrhea is a common side effect of HIV medications, and it can be a challenging symptom to manage. Mytesi works by inhibiting the secretion of chloride ions in the intestines, which helps to reduce the excessive fluid loss associated with diarrhea. It's important to note that Mytesi is not intended to treat infectious diarrhea, such as that caused by bacteria, viruses, or parasites. It is specifically designed to target the diarrhea associated with the use of HIV medications. Therefore, it is important to consult a healthcare professional to determine the underlying cause of the diarrhea before starting treatment with Mytesi. As with any medication, Mytesi may have potential side effects. These can include gastrointestinal symptoms such as nausea, flatulence, and abdominal pain. It is important to discuss any concerns or potential interactions with other medications with a healthcare provider before starting Mytesi.

How to use Mytesi?

To use Mytesi, follow the instructions provided by your healthcare provider and read the medication guide that comes with the prescription. Mytesi, also known by its generic name crofelemer, is a medication specifically designed to treat non-infectious diarrhea in adults who are taking HIV medications. The usual recommended dosage is 125 mg (two tablets) taken orally twice daily, with or without food. It's important to take the medication consistently and at the same times each day to ensure its effectiveness. If you miss a dose, take it as soon as you remember, but do not double the dose to make up for a missed one. Swallow the tablets whole, without crushing, breaking, or chewing them. If you have difficulty swallowing, you may speak to your healthcare provider for alternative administration options. Remember to keep taking Mytesi for as long as your healthcare provider has prescribed it, even if your symptoms improve. If you have any questions or concerns about how to use Mytesi or if you experience any side effects, it is crucial to consult your healthcare provider for guidance. They can provide the necessary support and monitor your progress while on this medication.

Before taking Mytesi (crofelemer), it's vital to be aware of the following warnings and precautions associated with its use: 1. Gastrointestinal Perforation: Mytesi should not be used in patients with a known or suspected gastrointestinal obstruction or perforation. If any signs or symptoms of these conditions develop during the use of Mytesi, medical attention should be sought immediately. 2. QT Prolongation: This medication has the potential to cause a heart rhythm condition known as QT prolongation. Individuals with a history of QT prolongation, low potassium or magnesium levels, or those taking medications that also prolong the QT interval should exercise caution when using Mytesi. Medical advice is necessary if any symptoms of unusual heartbeats or fainting occur. 3. Drug Interactions: Mytesi may interact with other medications, such as antiarrhythmics, antipsychotics, and certain antibiotics. Therefore, it is crucial to inform the prescribing healthcare professional about all medications being taken to minimize the risk of potential interactions. 4. Pregnancy and Breastfeeding: It is important to discuss the potential risks and benefits of using Mytesi during pregnancy or while breastfeeding. The healthcare provider can provide appropriate advice based on an individual's specific situation. 5. Adverse Reactions: The most common side effects observed with Mytesi include upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, and increased blood creatinine. Consulting a healthcare professional is necessary if any concerning side effects are experienced. As with any medication, it is essential to follow the prescribed dosage and instructions provided by the healthcare provider. Any concerns or questions regarding the use of Mytesi should be discussed with a qualified healthcare professional.

Before taking Mytesi, it is important to be aware of the following warnings: 1. Drug Interactions: Mytesi may interact with certain medications, including antiretroviral drugs used to treat HIV. It is crucial to inform your healthcare provider about all the medications you are taking to ensure there are no potential interactions that could affect the effectiveness or safety of Mytesi. 2. Pregnancy and Breastfeeding: The safety of Mytesi during pregnancy and breastfeeding has not been established. If you are pregnant, planning to become pregnant, or breastfeeding, it is essential to discuss with your healthcare provider the potential risks and benefits before starting Mytesi. 3. Gastrointestinal Disorders: Mytesi is specifically indicated for the treatment of diarrhea in patients using HIV medications. It may not be appropriate for other types of diarrhea, such as those caused by infections or other underlying medical conditions. It is crucial to accurately diagnose the cause of your diarrhea before initiating treatment with Mytesi. 4. Side Effects: Like any medication, Mytesi can cause side effects. The most common side effects include nausea, headache, abdominal pain, cough, flatulence, and upper respiratory tract infection. If you experience any severe or persistent side effects, it is important to consult your healthcare provider. 5. Dosage and Administration: Mytesi must be taken as prescribed by your healthcare provider. It is essential to follow the recommended dosage instructions and not exceed the prescribed amount. If you have any questions or concerns about the dosage or administration of Mytesi, consult your healthcare provider. Remember, this is not an exhaustive list of warnings associated with Mytesi. Always consult your healthcare provider or read the medication guide provided with the drug for complete and up-to-date information relevant to your individual circumstances.

Mytesi, also known as crofelemer, is a prescription drug specifically designed to treat non-infectious diarrhea in adult patients who are taking HIV medications. As with any medication, there is a potential for side effects. Common side effects associated with Mytesi include: 1. Headache: Some individuals may experience mild to moderate headache, often resolving on its own. 2. Flatulence (excessive gas): This medication may increase the production of intestinal gas, leading to bloating or flatulence. 3. Nausea: It's possible to experience mild nausea after taking Mytesi, but this side effect is generally temporary and improves with continued use. 4. Upper respiratory tract infection symptoms: Some patients may experience symptoms similar to a common cold, such as a runny or stuffy nose, sore throat, or cough. 5. Cough: Mytesi can occasionally cause a dry or non-productive cough. It is important to note that these side effects are generally mild and tolerable. However, if you experience severe or persistent side effects, it is recommended to consult with your healthcare provider. They are the best resource to assess your specific situation and provide personalized guidance.

The active ingredient in Mytesi is crofelemer. Crofelemer is derived from the bark of the Croton lechleri tree, which is native to South America. It is an antidiarrheal agent that works by blocking certain channels in the gastrointestinal tract, reducing the secretion of fluid from the intestines and helping to improve symptoms of diarrhea. Apart from crofelemer, other ingredients in Mytesi include microcrystalline cellulose, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, and specific colorants for tablet identification. It's important to note that Mytesi is only indicated for the relief of non-infectious diarrhea in adults who are taking HIV medications. It is not meant to treat other forms of diarrhea or replace other treatments prescribed by a healthcare professional. It's always essential to follow your healthcare provider's instructions and consult them regarding any concerns or questions you may have about your medication.

Storage of Mytesi, a brand-name prescription drug used to treat diarrhea in patients using HIV medications, should be done in accordance with the specific instructions provided by the manufacturer or healthcare provider. However, there are generally common guidelines for storing most medications. Ideally, Mytesi should be kept at room temperature, usually defined as around 68 to 77 degrees Fahrenheit (20 to 25 degrees Celsius). It is important to avoid exposing the medication to extreme temperatures, so it should be stored away from direct sunlight, heat sources, and moisture. Furthermore, it is recommended to keep Mytesi in its original packaging, which typically includes a tightly sealed container. This helps to protect the medication from external elements that could potentially alter its effectiveness. Lastly, it is important to keep Mytesi out of reach of children and pets to prevent accidental ingestion or misuse. If there are any specific storage instructions or precautions mentioned on the medication's label or provided by the prescribing healthcare professional, it is crucial to follow them accordingly. If you have any specific concerns about storing Mytesi or any other medication, it is advisable to consult your healthcare provider or pharmacist for personalized guidance to ensure proper storage conditions are maintained.